Hypertension, Cardiovascular–Renal Axis & Vascular Health

Hypertension and kidney disease share interconnected pathways involving endothelial dysfunction, RAAS imbalance, and vascular remodeling. Precision antihypertensive therapies guided by genomics and biomarkers improve control and reduce kidney damage. Renal denervation, mineralocorticoid receptor modulators, and novel vasodilatory agents offer new opportunities for patients with resistant hypertension. Integrated cardiovascular-renal management enhances patient survival and reduces complications.

    Related Conference of Hypertension, Cardiovascular–Renal Axis & Vascular Health

    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    April 27-28, 2026

    11th World Kidney Congress

    London, UK
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    Hypertension, Cardiovascular–Renal Axis & Vascular Health Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in